Zacks Investment Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-17,462	Closed	-$2.48M	–	528
2019 Q2	$2.48M	Sell	17,462 -43	-0.2%	-$5.83K	0.05%	229
2019 Q1	$2.54M	Sell	17,505 -1,683	-9%	-$221K	0.05%	220
2018 Q4	$2.17M	Buy	19,188 +601	+3%	+$75.2K	0.05%	221
2018 Q3	$2.5M	Buy	18,587 +975	+6%	+$120K	0.05%	238
2018 Q2	$1.98M	Buy	17,612 +1,037	+6%	+$112K	0.04%	278
2018 Q1	$1.77M	Buy	16,575 +1,448	+10%	+$156K	0.04%	289
2017 Q4	$1.66M	Buy	15,127 +298	+2%	+$32.4K	0.04%	306
2017 Q3	$1.6M	Buy	14,829 +1,736	+13%	+$178K	0.04%	284
2017 Q2	$1.32M	Buy	13,093 +473	+4%	+$43.5K	0.03%	304
2017 Q1	$1.14M	Buy	12,620 +858	+7%	+$72.9K	0.03%	325
2016 Q4	$896K	Buy	11,762 +9	+0.1%	+$684	0.03%	345
2016 Q3	$980K	Buy	11,753 +309	+3%	+$25.9K	0.03%	332
2016 Q2	$943K	Sell	11,444 -2,811	-20%	-$232K	0.03%	335
2016 Q1	$1.08M	Buy	+14,255	New	+$1.06M	0.03%	306
2015 Q1	–	Sell	-3,972	Closed	-$253K	–	637
2014 Q4	$253K	Buy	+3,972	New	+$249K	0.01%	541